|
1
|
Allemani C, Matsuda T, Di Carlo V,
Harewood R, Matz M, Nikšić M, Bonaventure A, Valkov M, Johnson CJ,
Estève J, et al: Global surveillance of trends in cancer survival
2000-14 (CONCORD-3): Analysis of individual records for 37 513 025
patients diagnosed with one of 18 cancers from 322 population-based
registries in 71 countries. Lancet. 391:1023–1075. 2018.
|
|
2
|
Sher T, Dy GK and Adjei AA: Small cell
lung cancer. Mayo Clin Proc. 83:355–367. 2008.
|
|
3
|
Noguchi M, Morikawa A, Kawasaki M, Matsuno
Y, Yamada T, Hirohashi S, Kondo H and Shimosato Y: Small
adenocarcinoma of the lung. Histologic characteristics and
prognosis. Cancer. 75:2844–2852. 1995.
|
|
4
|
Xu W, Chen B, Ke D and Chen X: TRIM29
mediates lung squamous cell carcinoma cell metastasis by regulating
autophagic degradation of E-cadherin. Aging (Albany NY).
12:13488–13501. 2020.
|
|
5
|
Caiola E, Iezzi A, Tomanelli M, Bonaldi E,
Scagliotti A, Colombo M, Guffanti F, Micotti E, Garassino MC,
Minoli L, et al: LKB1 Deficiency Renders NSCLC Cells Sensitive to
ERK Inhibitors. J Thorac Oncol. 15:360–370. 2020.
|
|
6
|
Dong B, Wu C, Huang L and Qi Y:
Macrophage-Related SPP1 as a potential biomarker for early lymph
node metastasis in lung adenocarcinoma. Front Cell Dev Biol.
9:7393582021.
|
|
7
|
Martinez-Zayas G, Almeida FA, Yarmus L,
Steinfort D, Lazarus DR, Simoff MJ, Saettele T, Murgu S, Dammad T,
Duong DK, et al: Predicting lymph node metastasis in non-small cell
lung cancer: Prospective external and temporal validation of the
HAL and HOMER Models. Chest. 160:1108–1120. 2021.
|
|
8
|
Tamai I, Nezu J, Uchino H, Sai Y, Oku A,
Shimane M and Tsuji A: Molecular identification and
characterization of novel members of the human organic anion
transporter (OATP) family. Biochem Biophys Res Commun. 273:251–260.
2000.
|
|
9
|
Leuthold S, Hagenbuch B, Mohebbi N, Wagner
CA, Meier PJ and Stieger B: Mechanisms of pH-gradient driven
transport mediated by organic anion polypeptide transporters. Am J
Physiol Cell Physiol. 296:C570–C582. 2009.
|
|
10
|
Hagenbuch B and Meier PJ: Organic anion
transporting polypeptides of the OATP/SLC21 family: Phylogenetic
classification as OATP/SLCO superfamily, new nomenclature and
molecular/functional properties. Pflugers Arch. 447:653–665.
2004.
|
|
11
|
Brenner S, Klameth L, Riha J, Schölm M,
Hamilton G, Bajna E, Ausch C, Reiner A, Jäger W, Thalhammer T and
Buxhofer-Ausch V: Specific expression of OATPs in primary small
cell lung cancer (SCLC) cells as novel biomarkers for diagnosis and
therapy. Cancer Lett. 356(2 Pt B): 517–524. 2015.
|
|
12
|
Chen X, Yi G, Zhou Y, Hu W, Xi L, Han W
and Wang F: Prognostic biomarker SLCO4A1 is correlated with tumor
immune infiltration in colon adenocarcinoma. Mediators Inflamm.
2023:49264742023.
|
|
13
|
Hays A, Apte U and Hagenbuch B: Organic
anion transporting polypeptides expressed in pancreatic cancer may
serve as potential diagnostic markers and therapeutic targets for
early stage adenocarcinomas. Pharm Res. 30:2260–2269. 2013.
|
|
14
|
Benito-Martin A and Peinado H: FunRich
proteomics software analysis, let the fun begin! Proteomics.
15:2555–2556. 2015.
|
|
15
|
Ellis K, Kerr J, Godbole S, Lanckriet G,
Wing D and Marshall S: A random forest classifier for the
prediction of energy expenditure and type of physical activity from
wrist and hip accelerometers. Physiol Meas. 35:2191–2203. 2014.
|
|
16
|
Kang J, Choi YJ, Kim IK, Lee HS, Kim H,
Baik SH, Kim NK and Lee KY: LASSO-Based machine learning algorithm
for prediction of lymph node metastasis in T1 Colorectal Cancer.
Cancer Res Treat. 53:773–783. 2021.
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
|
|
18
|
Horvath L, Thienpont B, Zhao L, Wolf D and
Pircher A: Overcoming immunotherapy resistance in non-small cell
lung cancer (NSCLC)-novel approaches and future outlook. Mol
Cancer. 19:1412020.
|
|
19
|
Liu WJ, Du Y, Wen R, Yang M and Xu J: Drug
resistance to targeted therapeutic strategies in non-small cell
lung cancer. Pharmacol Ther. 206:1074382020.
|
|
20
|
Lee EY and Muller WJ: Oncogenes and tumor
suppressor genes. Cold Spring Harb Perspect Biol.
2:a0032362010.
|
|
21
|
Stella GM, Luisetti M, Pozzi E and
Comoglio PM: Oncogenes in non-small-cell lung cancer: Emerging
connections and novel therapeutic dynamics. Lancet Respir Med.
1:251–261. 2013.
|
|
22
|
Thomas A, Liu SV, Subramaniam DS and
Giaccone G: Refining the treatment of NSCLC according to
histological and molecular subtypes. Nat Rev Clin Oncol.
12:511–526. 2015.
|
|
23
|
Cai Z and Liu Q: Understanding the Global
Cancer Statistics 2018: Implications for cancer control. Sci China
Life Sci. 64:1017–1020. 2021.
|
|
24
|
Barta JA, Powell CA and Wisnivesky JP:
Global epidemiology of lung cancer. Ann Glob Health. 85:82019.
|
|
25
|
Bille A, Woo KM, Ahmad U, Rizk NP and
Jones DR: Incidence of occult pN2 disease following resection and
mediastinal lymph node dissection in clinical stage I lung cancer
patients. Eur J Cardiothorac Surg. 51:674–679. 2017.
|
|
26
|
Kobayashi D, Nozawa T, Imai K, Nezu J,
Tsuji A and Tamai I: Involvement of human organic anion
transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport
across intestinal apical membrane. J Pharmacol Exp Ther.
306:703–708. 2003.
|
|
27
|
König J, Seithel A, Gradhand U and Fromm
MF: Pharmacogenomics of human OATP transporters. Naunyn
Schmiedebergs Arch Pharmacol. 372:432–443. 2006.
|
|
28
|
Wang XS, Wu SL, Peng Z and Zhu HH: SLCO4A1
is a Prognosis-Associated Biomarker Involved in Neutrophil-Mediated
Immunity in Thyroid Cancer. Int J Gen Med. 14:9615–9628. 2021.
|
|
29
|
Wright JL, Kwon EM, Ostrander EA,
Montgomery RB, Lin DW, Vessella R, Stanford JL and Mostaghel EA:
Expression of SLCO transport genes in castration-resistant prostate
cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on
prostate cancer outcomes. Cancer Epidemiol Biomarkers Prev.
20:619–627. 2011.
|
|
30
|
Buxhofer-Ausch V, Secky L, Wlcek K,
Svoboda M, Kounnis V, Briasoulis E, Tzakos AG, Jaeger W and
Thalhammer T: Tumor-specific expression of organic
anion-transporting polypeptides: Transporters as novel targets for
cancer therapy. J Drug Deliv. 2013:8635392013.
|
|
31
|
Stieger B and Hagenbuch B: Organic
anion-transporting polypeptides. Curr Top Membr. 73:205–532.
2014.
|
|
32
|
Takada K, Kashiwagi S, Asano Y, Goto W,
Kouhashi R, Yabumoto A, Morisaki T, Shibutani M, Takashima T,
Fujita H, et al: Prediction of lymph node metastasis by
tumor-infiltrating lymphocytes in T1 breast cancer. BMC Cancer.
20:5982020.
|
